Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Operating Expenses (2022 - 2025)

Cannabis Bioscience International Holdings' Operating Expenses history spans 4 years, with the latest figure at $138643.0 for Q4 2025.

  • For Q4 2025, Operating Expenses rose 9.97% year-over-year to $138643.0; the TTM value through Nov 2025 reached $519564.0, down 22.96%, while the annual FY2025 figure was $684281.0, 0.74% down from the prior year.
  • Operating Expenses for Q4 2025 was $138643.0 at Cannabis Bioscience International Holdings, up from $90841.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $305303.0 in Q2 2023 and bottomed at $70039.0 in Q1 2023.
  • The 4-year median for Operating Expenses is $143168.0 (2023), against an average of $170180.8.
  • The largest YoY upside for Operating Expenses was 163.53% in 2024 against a maximum downside of 68.68% in 2024.
  • A 4-year view of Operating Expenses shows it stood at $259099.0 in 2022, then tumbled by 44.74% to $143168.0 in 2023, then dropped by 11.94% to $126072.0 in 2024, then grew by 9.97% to $138643.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Operating Expenses are $138643.0 (Q4 2025), $90841.0 (Q3 2025), and $165311.0 (Q2 2025).